Quinazoline derivatives for inhibiting cancer cell growth...

Details Quinazoline derivatives for inhibiting cancer cell growth... Quinazoline derivatives for inhibiting cancer cell growth...

2011-08-23

2011-08-23

Jarrell, Noble (Department: 1622)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S266200, C514S266400, C544S235000

Reexamination Certificate

active

08003658

ABSTRACT:
The present invention relates to a novel quinazoline derivative and a pharmaceutically acceptable salt thereof for inhibiting the growth of cancer cells, a method for the preparation thereof and a pharmaceutical composition comprising same as an active ingredient.

REFERENCES:
patent: 2002/0082270 (2002-06-01), Himmelsbach et al.
patent: 602851 (1994-06-01), None
patent: WO 97/30034 (1997-08-01), None
patent: WO 99/09016 (1999-02-01), None
patent: WO 01/85760 (2001-11-01), None
patent: WO 02/068396 (2002-09-01), None
Cha et al. Journal of Medicinal Chemistry, 2009, 52, 6880-6888.
Cancer definition:, http://www.medterms.com/script/main/art.asp?articlekey=2580, accessed Nov. 27, 2007.
Albuschat, R., et al., “4-Anilinoquinazolines with Lavendustin A subunit as inhibitors of epidermal growth factor receptor tyrosine kinase: syntheses, chemical and pharmacological properties,” European J. of Medicinal Chemistry, 2004, 39, pp. 1001-1011.

Affiliated with

Also associated with

Rating

Quinazoline derivatives for inhibiting cancer cell growth... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinazoline derivatives for inhibiting cancer cell growth..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives for inhibiting cancer cell growth... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2723286